The survival and well‐being of patients treated for Cushing’s syndrome
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Pikkarainen L, Sane T, Reunanen A (Helsinki University Hospital and National Public Health Institute, Helsinki, Finland). The survival and well‐being of patients treated for Cushing’s syndrome. J. Intern Med 1999; 245: 463–468. Objective. The main aim of the study was to evaluate the survival, well‐being and working capacity of patients treated for Cushing’s syndrome. Design. The study was carried out by retrospectively analysing patient records from years 1981–94. Follow‐up time was extended from the time of diagnosis to the end of 1996. A questionnaire dealing with symptoms prior to and after therapy, and the quality of life estimated on a Visual Analogue Scale (VAS) was sent to all surviving patients. Setting. The study was performed in a university hospital. Main outcome measures. Survival, subjective well‐being, working capacity before and after treatment and disappearance of symptoms after treatment of Cushing’s syndrome. Results. During the follow‐up time 10 patients died out of a total of 74. The overall standardized mortality ratio (SMR) was 168% (95% CI 81–309%). The SMR of patients with pituitary disease was 267% (89–525%), and in patients with adrenal adenoma it was 135% (16–489%). Forty‐six per cent of the surviving patients stated that they felt fully recovered from the disease, but the proportion of patients having persisting symptoms after treatment was also noteworthy. The mean VAS score (range 0–100) was 19 (SD 14) before treatment and 82 (SD 18) after treatment (P < 0.001). After treatment, 81% of the patients were able to return to work, 11% retired because of disability, 5% retired because of age and 3% were on sick‐leave at the time of answering the questionnaire. During the follow‐up time, 42% of the patients with pituitary disease suffered a relapse. However, the effect of the relapse on well‐being was not significant. Conclusions. The mortality risk of patients treated for Cushing’s disease was not significantly increased compared with that of the general population. Many symptoms persisted even years after therapy. After clinical recovery, working ability was not always regained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROSS, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92749-0 · Cited by 390
The growth hormone deficiency syndrome in adults
Cuneo, R. C., Salomon, F., McGauley, G. A., & Sönksen, P. H. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02347.x · Cited by 375
Cited by
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Complications of Cushing's syndrome: state of the art
Pivonello, R., Isidori, A. M., De Martino, M. C., Newell-Price, J., Biller, B. M. K., & Colao, A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00086-3 · Cited by 641
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619
The Treatment of Cushing's Disease
Pivonello, R., De Leo, M., Cozzolino, A., & Colao, A. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 465
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Metadata
- Authors
- Pikkarainen, L., Sane, T., & Reunanen, A.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 1999-05
- Volume
- 245
- Issue
- 5
- Pages
- 463-468
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2097713817
- Cited by
- 120
- References
- 2
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The survival and well‐being of patients treated for Cushing’s syndrome. https://app.cochat.ai/papers/10.1046/j.1365-2796.1999.00483.x
- The paper
- Pikkarainen, L., Sane, T., & Reunanen, A. (1999). The survival and well‐being of patients treated for Cushing’s syndrome. Journal of Internal Medicine. https://doi.org/10.1046/j.1365-2796.1999.00483.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.